I was diagnosed with type 1 diabetes as a child. Since then, I knew I wanted to become a doctor to care for others with chronic illness and help patients see that they can live a full life. As an pediatric endocrinologist and diabetes doctor, I treat children and adolescents with type 1 diabetes, Turner syndrome, steroid-induced diabetes, adrenal insufficiency and general endocrine disorders.
For me, it’s essential to listen to a patient to see if they are thriving and how their health is impacting their life. I try to understand what I can do to help them manage their medical issues and reach their goals. I like to work as part of a medical team to determine the patient’s care plan that works best and is safe.
In my research, my colleagues and I want to learn how technology can be used to improve diabetes care. We are also looking at how to screen and identify diabetes complications, how to prevent or treat hypoglycemia associated with type 1 diabetes, and how to identify the risks of diabetes in patients with other conditions, such as Turner syndrome.
When I’m not at work, I love spending time with my husband and children. We like to play freeze tag and have movie nights at home with popcorn. I also have been active with diabetes camps for the last 30 years.
MD: University of Cincinnati, Cincinnati, OH, 2006.
Residency: Pediatrics, University of Massachusetts, Worcester, MA.
Fellowship: Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Certification: Pediatric Endocrinology, 2015.
Type 1 diabetes; Turner syndrome; steroid induced diabetes; general endocrine disorders
Response to hypoglycemia in patients with type 1 diabetes; beta cell function in Turner syndrome; kidney disease in type 1 diabetes
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Basal and Bolus Insulin Distribution According to Treatment Modality: Data from SWEET Diabetes Registry. Pediatric Diabetes. 2023; 2023:1-8.
Twelve-month psychosocial outcomes of continuous glucose monitoring with behavioural support in parents of young children with type 1 diabetes. Diabetic Medicine. 2023; 40:e15120.
Short-term fasting lowers glucagon levels under euglycemic and hypoglycemic conditions in healthy humans. JCI insight. 2023; 8:e169789.
Increase in newly diagnosed type 1 diabetes in youth during the COVID-19 pandemic in the United States: A multi-center analysis. Pediatric Diabetes. 2022; 23:433-438.
Increased Prevalence of Beta-Cell Dysfunction despite Normal HbA1c in Youth and Young Adults with Turner Syndrome. Hormone Research in Paediatrics: from developmental endocrinology to clinical research. 2021; 94:297-306.
C-peptide enhances glucagon secretion in response to hyperinsulinemia under euglycemic and hypoglycemic conditions. JCI insight. 2021; 6:e148997.
Liver glycogen-induced enhancements in hypoglycemic counterregulation require neuroglucopenia. American Journal of Physiology: Endocrinology and Metabolism. 2021; 320:E914-E924.
A Randomized Clinical Trial Assessing Continuous Glucose Monitoring (CGM) Use With Standardized Education With or Without a Family Behavioral Intervention Compared With Fingerstick Blood Glucose Monitoring in Very Young Children With Type 1 Diabetes. Diabetes Care. 2021; 44:464-472.
Readiness for transition to adult care in adolescents and young adults with Turner syndrome. Journal of Pediatric Endocrinology and Metabolism. 2020; 33:1165-1171.
A Balanced Approach: Meeting the Needs of Medical Students and Faculty Educators in Pediatrics. The Journal of Pediatrics. 2019; 215:4-6.